This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Alison Crawford, PhD
Senior Staff Scientist, Oncology and Angiogenesis at Regeneron Pharmaceuticals


Dr. Alison Crawford is a Senior Staff Scientist in the department of Oncology and Angiogenesis at Regeneron Pharmaceuticals, Inc. She has >18 years of immunology research experience, including > 8 years in the pharmaceutical industry. She specializes in the pre-clinical development of bispecific antibodies for oncology indications. She completed her BSc in Immunology from Glasgow University before being admitted to the Wellcome Trust Ph.D. program at Edinburgh University where she focused on T cell memory. Her post-doctoral work at the University of Pennsylvania examined T cell exhaustion during chronic viral infection and the role of checkpoint inhibition in alleviating this exhaustion. At Regeneron Pharmaceuticals, she leads a team that develops pre-clinical models to examine bispecific antibodies targeting solid tumors. She led the in vivo pre-clinical research efforts on REGN4018 (MUC16xCD3) to advance the antibody through to IND submission.

Agenda Sessions

  • A Mucin 16 Bispecific T cell-engaging Antibody for the Treatment of Ovarian Cancer